Participants
Contact
Article by Cristina Sáez on Women Entrepreneurs for the ES supplement of La Vanguardia. Among those in the spotlight is Teresa Tarragó, who in 2011, together with Ernest Giralt, set up Iproteos. Specializing in drug discovery for diseases that affect the central nervous system, this biotech company came about as a result of research performed by Tarragó and Giralt in the Peptides and Proteins Lab at IRB Barcelona.
Profile of @Teresa_Tarragó and Iproteos (PDF Spanish)
Read the full article "Mujeres Emprendedoras"
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
